The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type.
Open accessAbstract
We have previously shown that CD4+ T cells from allergic individuals are predisposed to produce interleukin (IL)-4 in response to allergens, and that allergen immunotherapy greatly reduced IL-4 production in an allergen-specific fashion. The mechanism that results in the reduction of IL-4 synthesis in treated individuals is unknown, but because clinical improvement during immunotherapy is associated with the administration of the highest doses of allergen, we hypothesized that high concentration of allergen results in the downregulation of IL-4 synthesis in CD4+ T cells. In this report, we demonstrated that CD4+ T cells from allergic donors produced high levels of IL-4 when stimulated with low concentrations of allergen (0.003-0.01 micrograms/ml), particularly when B cell-enriched populations presented the antigen. In contrast, the same responding CD4+ T cell population produced little IL-4 when stimulated with high concentrations of allergen (10-30 micrograms/ml), especially when monocytes were used as antigen-presenting cells (APC). The quantity of IL-4 produced was also found to be inversely related to the extent of proliferation of the CD4+ T cells in response to allergen/antigen; maximal proliferation of CD4+ T cells occurred in response to high concentrations of antigen when IL-4 production was minimal. Antigen presentation by B cell-enriched populations, instead of monocytes, induced less CD4+ T cell proliferation, but induced much greater IL-4 synthesis. Moreover, the addition of increasing numbers of APC (either B cells or monocytes) to cultures containing a constant number of responder T cells resulted in increased T cell proliferation and decreased IL-4 production. These results indicate that the circumstances under which memory T cells are activated, as well as the strength of the proliferative signal to T cells, greatly affect the quantity of IL-4 produced. Thus, our observations that the cytokine profile of allergen-specific memory CD4+ T cells can indeed be modulated by the antigen dose and APC type suggest that methods that preferentially enhance allergen uptake by monocytes and that enhance T cell proliferation will improve the clinical efficacy of immunotherapy in the treatment of allergic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced Macrophages
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., & Murphy, K. M. (1993) · Science · doi:10.1126/science.8097338 · Cited by 3,134
Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma
Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R., & Kay, A. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260504 · Cited by 2,768
Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M. P., Maggi, E., Trinchieri, G., & Romagnani, S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1199 · Cited by 1,665
Antigen-specific interaction between T and B cells
Lanzavecchia, A. (1985) · Nature · doi:10.1038/314537a0 · Cited by 1,412
IL‐4 directs the development of Th2‐like helper effectors
Swain, S. L., Weinberg, A. D., English, M., & Huston, G. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.11.3796 · Cited by 1,254
Hsieh, C. S., Heimberger, A. B., Gold, J. S., O'Garra, A., & Murphy, K. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6065 · Cited by 747
Parronchi, P., Macchia, D., Piccinni, M. P., Biswas, P., Simonelli, C., Maggi, E., Ricci, M., Ansari, A. A., & Romagnani, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4538 · Cited by 617
Durham, S. R., Ying, S., Varney, V. A., Jacobson, M. R., Sudderick, R. M., Mackay, I. S., Kay, A. B., & Hamid, Q. A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.8.2390 · Cited by 557 · cited 1×
“Inasmuch as the development of allergic disease with increased IgE synthesis is thought to be caused by excessive production of 1D4 in allergen-specific CD4+ T cells (10-15), allergen immunotherapy, by reducing IL-4 synthesis and altering the cytokine profiles of allergen-”
BackgroundSeparation of IL-4 Production from Th Cell Proliferation by an Altered T Cell Receptor Ligand
Evavold, B. D., & Allen, P. M. (1991) · Science · doi:10.1126/science.1833816 · Cited by 549
Cited by
INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative Approaches
Constant, S. L., & Bottomly, K. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.297 · Cited by 1,459
Role of interleukin 10 in specific immunotherapy.
Akdis, C. A., Blesken, T., Akdis, M., Wüthrich, B., & Blaser, K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2250 · Cited by 973
Mechanisms of allergen-specific immunotherapy
Akdis, C. A., & Akdis, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.030 · Cited by 803
Hosken, N. A., Shibuya, K., Heath, A. W., Murphy, K. M., & O'Garra, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1579 · Cited by 743
Indoor allergens and asthma:Report of the Third International Workshop
Platts-Mills, T. A. E., Vervloet, D., Thomas, W. R., Aalberse, R. C., & Chapman, M. D. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70292-6 · Cited by 727
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
VALENTA, LIDHOLM, NIEDERBERGER, HAYEK, KRAFT, & GRÖNLUND (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00653.x · Cited by 531
Till, S. J., Francis, J. N., Nouri-Aria, K., & Durham, S. R. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.024 · Cited by 434
Immunologic changes associated with allergen immunotherapy
Durham, S. R., & Till, S. J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70079-x · Cited by 338
Interleukin-4 and lnterleukin-13: Their Similarities and Discrepancies
Chomarat, P., & Banchereau, J. (1998) · International Reviews of Immunology · doi:10.3109/08830189809084486 · Cited by 331
The future of antigen-specific immunotherapy of allergy
Valenta, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri824 · Cited by 314
Ferreira, F., Hirtenlehner, K., Jilek, A., Godnik-Cvar, J., Breiteneder, H., Grimm, R., Hoffmann-Sommergruber, K., Scheiner, O., Kraft, D., Breitenbach, M., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.599 · Cited by 310
Targeting B cells and plasma cells in autoimmune diseases
Hofmann, K., Clauder, A.-K., & Manz, R. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00835 · Cited by 294
Noninjection routes for immunotherapy
Canonica, G. W., & Passalacqua, G. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.129 · Cited by 283
Srikiatkhachorn, A., & Braciale, T. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.3.421 · Cited by 280
Ferreira, F., Ebner, C., Kramer, B., Casari, G., Briza, P., Kungl, A. J., Grimm, R., Jahn‐schmid, B., Breiteneder, H., Kraft, D., et al. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.2.231 · Cited by 271
Type I IFNs Inhibit Human Dendritic Cell IL-12 Production and Th1 Cell Development
McRae, B. L., Semnani, R. T., Hayes, M. P., & van Seventer, G. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4298 · Cited by 260
Rate, A., Upham, J. W., Bosco, A., McKenna, K. L., & Holt, P. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.72 · Cited by 88
Metadata
- Authors
- Secrist, H., DeKruyff, R. H., & Umetsu, D. T.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-03-01
- Volume
- 181
- Issue
- 3
- Pages
- 1081-1089
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2164025040
- Cited by
- 262
- References
- 36
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.